INSIGHTS ON DRUG DEVELOPMENT

• How To Achieve Late-Phase Success In Complex OSD Development

  Late-phase OSD scale-up demands more than technical know-how. This paper examines the frameworks, tools, and partnership models that determine whether promising molecules reach commercial production reliably.

• A Sensory Panel Study With The Focus On High-Intensity Sweeteners

  Gain insight into the sensory performance of five high-intensity sweeteners in a simulated bitter formulation, including their effects on sweetness, bitterness, aftertaste, and covering ability.

• Overview Of Hot Melt Extrusion And Its Pharmaceutical Applications

  More than 40% of NCEs face aqueous solubility challenges. Here, we examine how hot melt extrusion addresses solubility, modified release, abuse deterrence, and scale-up across pharmaceutical development.

• Discovery Core Rheometer: Easy To Use. Hard To Beat.

  Explore how advanced rheological testing delivers deeper insight into material behavior, from flow and yield stress to quality control decisions, using guided workflows that simplify setup.

• Quality Assurance In IVT RNA Vaccine Development Using Electrophoresis

  2/20/2025

  Discover advanced solutions for IVT RNA synthesis, focusing on enhancing fidelity in throughput, innovative technologies, and methodologies to optimize your RNA research and development processes.

• Inside Bioprocessing: Microbial Media

  11/4/2025

  Learn the reasons why the animal origin-free trend in bioprocessing has taken so long to reach microbial bioproduction and the technical hurdles overcome during the development of Gibco CD Bacto Supreme.

• Assessment Of Compound Toxicity Effects With High-Content Imaging

  3/17/2025

  3D cellular models and bioprinting enhance drug safety predictions and offer precise spatial control. Explore an automated method for generating liver models to improve reproducibility and reliability in toxicity testing.

• Ask Us Anything: Matthew Schiesher On Validation During Tech Transfer

  7/23/2026

  Matthew Schiesher, Head of R&D at Cambrex Charles City, on validating processes under the clock — and how running multiple sites in parallel shortens the path to launch when patients are waiting.

• Small Molecule Orphan Drugs: Status Quo, Challenges, And Perspectives

  3/11/2026

  By establishing robust manufacturing processes and scalable production strategies from the outset, developers can help de-risk orphan drug production, improve efficiency, and position their programs for greater long-term success.